Journal List > Pediatr Infect Vaccine > v.24(2) > 1095923

Jung, Park, and Oh: A Retrospective Analysis of Use in Hospitalized Children with Upper Respiratory Tract Infection

Abstract

Purpose

The inappropriate prescription of antibiotics in children with upper respiratory tract infection (URTI) is common. This study evaluated the factors that influence antibiotics use in hospitalized children with viral URTI confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) assay.

Methods

The medical records of admitted patients who performed RT-PCR assay for respiratory virus pathogens from January 2013 to November 2014 were examined. The demographic and clinical features were compared between patients who were administered antibiotics at admission and those who were not. We also investigated differences between children who continued antibiotics and those who stopped antibiotics after a viral pathogen was identified.

Results

In the total 393 inpatients, the median age was 23 months (interquartile range, 13 to 41.3 months). Antimicrobial agents were prescribed in 79 patients (20.1%) at admission. Patients with acute otitis media (AOM) had higher rates of antibiotics prescription than those without AOM (48.1% vs. 2.2%, P<0.001), with an adjusted odds ratio of 91.1 (95% confidence interval, 30.5 to 271.7). Level of high-sensitivity C-reactive protein and the proportion of acute rhinosinusitis were also significantly associated with antibiotics use (P<0.001). Among the 44 patients with viruses identified using the RT-PCR method during hospitalization, antibiotic use was continued in 28 patients (63.6%). AOM was statistically associated with continued antibiotic use in the patients (P=0.002).

Conclusions

Although the respiratory virus responsible for URTI etiology is identified, clinicians might not discontinue antibiotics if AOM is accompanying. Therefore, careful diagnosis and management of AOM could be a strategy to reduce unjustified antibiotic prescriptions for children with URTI.

Introduction

Acute respiratory tract infection is the most common illness to visit to pediatric health facilities1). Although it has been reported that upper respiratory tract infections (URTIs) are mostly viral in origin and are typically self-limiting in children, unnecessary antibiotics are frequently prescribed23). In Korea, the overall antibiotic prescription rate in pediatric outpatients with URTIs was 55.4% in 20114). Despite the recent decline in antibiotic prescription rates, this rate is still much higher than that of Western countries56).
The proper use of antibiotics has been challenging due to difficulties distinguishing between bacterial and viral infections in clinical practice78). These limitations have inspired a great deal of research into methods for verifying possible viral pathogens. Prior retrospective studies have suggested that a rapid antigen test could reduce the use of antibiotics and the duration of hospitalization910). However, other studies have reported contradictory results11). Recently, reverse transcriptase-polymerase chain reaction (RT-PCR) analyzes have become more sensitive than traditional methods, such as viral culture, direct fluorescent assays, and rapid antigen detection tests12).
The development of a RT-PCR test was expected to result in further increases in diagnostic yield and a reduction in antibiotic prescription13). However, several recent studies in pediatric populations have shown that the introduction of RT-PCR test has not reduced antibiotic use in clinical practice814).
This study was conducted to evaluate the factors associated with antibiotic use in children hospitalized with URTI and to identify the clinical characteristics associated with continued use of prescription antibiotics notwithstanding the detection of a respiratory virus by RT-PCR.

Materials and Methods

1. Study population

The medical records of the Department of Pediatrics, Kosin University Gospel Hospital (Busan, Korea), a tertiary care center, were analyzed. Data were collected by reviewing the electronic medical records of all cases of admitted children <18 years of age, on whom multiplex RT-PCR using the Seeplex RV7 Detection System (Seegene Inc., Seoul, Korea) were performed between January 2013 and November 2014. Among these patients, those being initially admitted for respiratory symptoms with fever and ultimately diagnosed with an URTI at discharge were eligible for inclusion. Patients treated with chemotherapy, immunosuppressive therapy, stem cell transplantation, corticosteroid, or mechanical ventilation in the pediatric intensive care unit and those receiving antibiotic therapy due to culture-proven bacterial infections (bacterial pharyngotonsilitis, urinary tract infection, bacteremia, and meningitis) were excluded. Further excluded were all newborns that had been hospitalized since birth. This study was reviewed and approved by the Institutional Review Board of Kosin University Gospel Hospital (2015-02-020).

2. Data collection

Demographic characteristics and clinical and laboratory information were obtained from electrical medical records. Clinical information included the diagnoses made by pediatrician at admission and discharge, complications, duration of hospital stay, fever duration, whether antibiotics were used before and after the respiratory virus results being reported, and antibiotic classification. Complications of URTI at admission were classified as either acute otitis media (AOM) or acute rhinosinusitis. Pediatricians had made diagnoses using portable otoscope and if tympanic membrane did not visible, video otoscope was used. Antibiotics were categorized into three families including penicillins (ampicillin, ampicillin-sulbactam, amoxicillin, and amoxicillin-clavulanate), cephalosporins (cefotaxime, ceftriaxone, and cefpodoxime), and macrolides (clarithromycin). Macrolides were given by the oral route, other antibiotics by the intravenous injections.
We recorded laboratory variables including white blood cell (WBC) count, high-sensitivity C-reactive protein (hS-CRP), erythrocyte sedimentation rate (ESR), RT-PCR results, and report dates. The blood samples of children were obtained at admission, and results were reported within 3 hours. Respiratory virus RT-PCR assays using a nasopharyngeal swab specimen were performed at the Clinical Microbiological Laboratory at Kosin University Gospel Hospital. Seven viruses (influenza viruses A and B, respiratory syncytial virus, adenovirus, parainfluenza virus, rhinovirus, and human metapneumovirus) were included in the panel. The assays were conducted in every Monday and Thursday.

3. Statistical analysis

All data were analyzed using SPSS version 22 (IBM Co., Armonk, NY, USA). Categorical variables were compared using the chi-square test or Fisher exact test to determine the relationships between antibiotic prescriptions and clinically informed variables. The Student t-test was used to compare continuous variables, and data without a normal distribution were analyzed with the Mann-Whitney U test. P-value less than 0.05 was considered to indicate statistical significance. All variables that were significant in the previous test were evaluated with the use multivariable logistic-regression models to analyze factors associated with initial antibiotics prescription.

Results

During the study period, RT-PCR assays were performed on a total of 1,277 patients upon admission. Of these, 393 inpatients met the inclusion criteria. The median (interquartile range [IQR]) age of inpatients meeting the inclusion criteria was 23 months (IQR, 13 to 41 months) (Table 1). Acute nasopharyngitis (67.4% , 265/393), acute pharyngotonsillitis (27.2%, 107/393), and acute laryngitis (5.4%. 21/393) were diagnosed in these patients. AOM was observed in 45 children (11.5%) and acute rhinosinusitis in 14 (3.6%). Four patients (1%) were diagnosed with concurrent AOM and acute rhinosinusitis.
Antibiotics were prescribed for 79 patients (20.1%) with URTI upon admission. The demographic and clinical characteristics of the patients who received antibiotics were compared with those of the 314 patients (79.9%) who did not receive antibiotics treatment (Table 2). Among those who received antibiotics, diagnoses of AOM and acute rhinosinusitis were more common (48.1% vs. 2.2%, 16.5% vs. 0.3%, respectively). The median WBC count (12,190/mm3 vs. 10,840/mm3, P=0.006), the median serum level of hS-CRP (2.1 mg/dL vs. 0.7 mg/dL, P<0.001) and the median ESR (23 mm/hr vs. 14 mm/hr, P<0.001) were higher in patients who received antibiotics than in those who did not. Risk factors for initial antibiotics use were AOM, acute rhinosinusitis, and HS-CRP. Patients having AOM, as compared with those who did not, had a relative risk of receiving antibiotics of 91.1 (95% confidence interval, 30.5 to 271.7; P<0.001). The odd ratio for initial antibiotics use, when level of WBC count and ESR increased, did not significantly increased on multivariate analysis.
Antibiotics were used in 18.5% (49/265) children diagnosed with acute nasopharyngitis and in 24.3% (26/107) with acute pharyngotonsilitis (Table 3). A single antibiotic agent was prescribed to 77 patients (97.5%), and combination therapy was administered to two patients. Among single-agent therapies, the penicillin family (68.3%, 54/79) was the most common agent used for each URTI, followed by cephalosporins (29.1%, 23/79).
Respiratory viruses were detected using the RT-PCR test in 223 (56.7%) of 393 patients. Of these, 43 patients (19.3%) were positive for two viruses, two patients (0.9%) were positive for three viruses, and one patient (0.5%) was positive for four concurrent viruses . Adenovirus (28.3%, 52/184) and rhinovirus (27.7%, 51/184) were commonly identified in acute nasopharyngitis. Adenovirus (44.6%, 29/65) was the most frequently found pathgen related to acute pharyngotonsilitis. In patient with acute laryngitis, parainfluenza was more commonly detected (50%, 12/24) (Fig. 1). In one-thirds of patients (17/52) diagnosed with AOM, viruses did not detected. Among the rest, adenovirus (21%) and rhinovirus (15.4%) was identified.
Of the 79 patients who received antibiotics, 35 patient s were discharged or had discontinued antibiotics earlier. The remaining patients (n=44) have treated antibiotics when RT-PCR results had been reported. Antibiotics were continued in 28 patients (63.6%) after clinicians were informed that viruses had been identified using the RT-PCR method. A comparison of the characteristics of children who either continued or discontinued antibiotic therapy after the identification of a viral pathogen is presented in Table 4. AOM was a statistically significant diagnosis in patients who maintained antibiotic usage (P=0.002). There were no significant differences in age, duration of fever, laboratory findings, or length of hospitalization between the two groups.

Discussion

In this study, we analyzed the factors related to use antibiotics in patients with URTI. Children who were administered antibiotics at admission had a higher prevalence of AOM compared with those who did not. Similarly, the proportion of AOM was also greater in patients who continued antibiotics therapy, even when informed of respiratory virus presence, than in patients who stopped antibiotics. Therefore, diagnosis of AOM might affect antibiotic prescription behavior in children with URTI.
AOM is a major reason for antibiotic use in children1516). The rate of antibiotic prescriptions for AOM in our trial (84.4%) was consistent with rates reported in other Korean studies (86.1%)17). This rate varies from 56% in the Netherlands to 95% in the USA, Canada, and Australia18). In response to concerns about the emergence of antibiotic-resistant microorganisms and the economic burden of disease caused by antibiotic resistance, the need for accurate diagnosis of AOM to minimize unnecessary treatment has been globally agreed upon192021).
However, accurate diagnosis of AOM could be difcfiult in infants and young children because of incooperation with the examination and cerumen barrier of tympanic membrane. Recently published American Academy of Pediatrics guideline of AOM endorses strict otoscopic diagnostic criteria to differentiate AOM from otitis media with effusion19). Therefore, a cautious examination of the tympanic membrane and understanding the wide clinical spectrum of otitis media are required to achieve a high degree of diagnostic accuracy22). In addition to this effort to accurate diagnosis of AOM, “watchful waiting” in selected children without progression of signs or symptoms within 48 to 72 hours before prescribing antibiotics for AOM has been recommended to clinicians1923).
Twenty percent (79/393) of inpatients with URTIs were treated with antimicrobial agents during this study period. This proportion was lower than that of tertiary hospitals analyzed in a recent study evaluating pediatric outpatients with URTI from 2009 to 2011 in Korea (49.5%)4).
Measuring serum CRP as a means of differentiating between viral and bacterial infections is known to be helpful in making the decision whether or not to prescribe antimicrobial agents to children with acute respiratory illness24). A previous study of 176 children determined that serum CRP level exceeding 4 mg/dL probably implied bacterial respiratory infection25). Of this study's subjects, children who received antibiotics upon admission had higher level of hS-CRP than those who did not. However, the difference in the level of mean hS-CRP was not likely to impact on initial antibiotics use in the clinical setting. The lower odd ratio for hS-CRP associated with initial antibiotics prescription could explain its discrepancy.
In the present study, although a virus was detected using an RT-PCR assay, the antibiotic administration was continued in 28 patients (62.2%, 28/45). This finding corresponded with previous studies suggesting that detecting a viral respiratory pathogen using RT-PCR analysis result did not reduce antibiotic use81426). Other randomized trials evaluating the effect of viral RT-PCR results have presumed that similar findings were explained by the clinician's concerns regarding bacterial superinfection in patients with acute respiratory illness8). Although it is accepted that respiratory virus infection predisposes patients to subsequent bacterial respiratory superinfection, the virtual incidence of these serious bacterial infections remains ambiguous1127).
Our study has several limitations. First, the diagnosis of AOM was not made precisely. The results were not deduced based on an exact diagnosis protocol but electronic medical records. Second, the RT-PCR analyses in our study were performed only twice a week, resulting in discharged patients before PCR results was reported. This fact could have decreased the advantage provided by RT-PCR as a rapid diagnostic tool, which could have an effect on antibiotic prescription rates. However, other studies have revealed that rapid communication of RT-PCR results did not reduce antibiotic use28). Third, it is unlikely that positive RT-PCR results always imply a true viral respiratory tract infection. In a recent study that compared viral PCR results from children with respiratory infection to asymptomatic matched controls, respiratory viruses, such as bocavirus, rhinovirus, adenovirus, coronavirus, and enterovirus, were frequently detected in asymptomatic matched controls29). Fourth, this trial was not performed for all inpatients who were diagnosed with an upper respiratory virus but was limited to subjects who received viral RT-PCR analysis. In addition, the performance of our study in a tertiary care center, where antibiotic use is less likely than in a primary care setting, limits the ability to extend our results to a general pediatric clinic. Despite these limitations, the strength of the present study is that it was based on an actual clinical practice.
In this study of children with URTI, antibiotic prescriptions were more frequently found among patients with AOM than among those without AOM. After respiratory viral pathogen was identified using RT-PCR, maintenance of antibiotic treatment were more common in the children with AOM than those without AOM. Therefore, accurate diagnosis of AOM could be a clue in reducing the unnecessary antibiotics use in children with viral URTIs. Well-designed education programs and studies to select patients who might benefit from antimicrobial agents are also important to improve management of AOM. Future prospective studies will be required to develop strategies that can change the prescribing behavior of physicians to minimize unjustified antibiotic use in viral infections.

Figures and Tables

Fig. 1

Viruses identified in 393 nasopharyngeal swabs obtained from admitted children with upper respiratory tract infection. Among patients infected with viral particles, 42 patients were positive for two viruses, two patients were positive for three viruses, and one patient was positive for four concurrent viruses.

piv-24-87-g001
Table 1

Baseline Characteristics of the Inpatients with Upper Respiratory Tract Infections

piv-24-87-i001

Values are presented as median (interquartile range) or number (%).

Abbreviations: AOM, acute otitis media; WBC, white blood cell; hS-CRP, high-sensitivity C-reactive protein; ESR, erythrocyte sedimentation reaction.

Table 2

Factors Associated with Initial Antibiotics Prescriptions in the Patients Who Diagnosed as Upper Respiratory Tract Infection

piv-24-87-i002

Values are presented as median (interquartile range) or number (%).

*P-values are for comparisons across groups, with the use of Fisher exact test or chi-square test for categorical variables and the Mann-Whitney U test for continuous variables.

The multivariate model included only effects with P-value of less than 0.05.

Abbreviations: CI, confidence interval; AOM, acute otitis media; WBC, white blood cell; hS-CRP, high-sensitivity C-reactive protein; ESR, erythrocyte sedimentation reaction.

Table 3

Prescribed Antibiotics for Hospitalized Children with Upper Respiratory Tract Infection

piv-24-87-i003

Values are presented as number (%).

*Acute otitis media and acute rhinosinusitis were considered as the complications of upper respiratory tract infection.

Macrolides were given by the oral route, other antibiotics by the intravenous injections.

Table 4

Characteristics of Children Who Either Continued or Discontinued Antibiotic Use after Respiratory Viruses were Detected with Reverse Transcriptase-Polymerase Chain Reaction

piv-24-87-i004

Values are presented as median (interquartile range), number (%), or mean±standard deviation.

*P values are for comparisons across groups, with the use of Fisher exact test for categorical variables and the Mann-Whitney U test for continuous variables.

Abbreviations: AOM, acute otitis media; WBC, white blood cell; hS-CRP, high-sensitivity C-reactive protein; ESR, erythrocyte sedimentation reaction.

References

1. Monto AS. Epidemiology of viral respiratory infections. Am J Med. 2002; 112:Suppl 6A. 4S–12S.
crossref
2. Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016; 315:1864–1873.
crossref
3. Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011; 128:1053–1061.
crossref
4. Shin SM, Shin JY, Kim MH, Lee SH, Choi S, Park BJ. Prevalence of antibiotic use for pediatric acute upper respiratory tract infections in Korea. J Korean Med Sci. 2015; 30:617–624.
crossref
5. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009; 302:758–766.
crossref
6. Mangione-Smith R, Wong L, Elliott MN, McDonald L, Roski J. Measuring the quality of antibiotic prescribing for upper respiratory infections and bronchitis in 5 US health plans. Arch Pediatr Adolesc Med. 2005; 159:751–757.
crossref
7. Hersh AL, Jackson MA, Hicks LA. American Academy of Pediatrics Committee on Infectious Diseases. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013; 132:1146–1154.
crossref
8. van de Pol AC, Wolfs TF, Tacke CE, Uiterwaal CS, Forster J, van Loon AM, et al. Impact of PCR for respiratory viruses on antibiotic use: theory and practice. Pediatr Pulmonol. 2011; 46:428–434.
crossref
9. Sharma V, Dowd MD, Slaughter AJ, Simon SD. Effect of rapid diagnosis of influenza virus type a on the emergency department management of febrile infants and toddlers. Arch Pediatr Adolesc Med. 2002; 156:41–43.
crossref
10. Byington CL, Castillo H, Gerber K, Daly JA, Brimley LA, Adams S, et al. The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital. Arch Pediatr Adolesc Med. 2002; 156:1230–1234.
crossref
11. Doan QH, Kissoon N, Dobson S, Whitehouse S, Cochrane D, Schmidt B, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. 2009; 154:91–95.
crossref
12. Krause JC, Panning M, Hengel H, Henneke P. The role of multiplex PCR in respiratory tract infections in children. Dtsch Arztebl Int. 2014; 111:639–645.
crossref
13. Pozzetto B, Grattard F, Pillet S. Multiplex PCR theranostics of severe respiratory infections. Expert Rev Anti Infect Ther. 2010; 8:251–253.
crossref
14. Wishaupt JO, Russcher A, Smeets LC, Versteegh FG, Hartwig NG. Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial. Pediatrics. 2011; 128:e1113–e1120.
crossref
15. Chonmaitree T, Alvarez-Fernandez P, Jennings K, Trujillo R, Marom T, Loeffelholz MJ, et al. Symptomatic and asymptomatic respiratory viral infections in the first year of life: association with acute otitis media development. Clin Infect Dis. 2015; 60:1–9.
crossref
16. Stockmann C, Ampofo K, Hersh AL, Carleton ST, Korgenski K, Sheng X, et al. Seasonality of acute otitis media and the role of respiratory viral activity in children. Pediatr Infect Dis J. 2013; 32:314–319.
crossref
17. Health Insurance Review & Assessment Service. The results of appropriate antibiotics prescription in chilren with acuteotitis media 2013 [Internet]. Wonju: HIRA;c2013. cited 2017 Jun 10. Available from: http://www.hira.or.kr.
18. Venekamp RP, Sanders SL, Glasziou PP, Del Mar CB, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2015; (6):CD000219.
crossref
19. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013; 131:e964–e999.
crossref
20. Vouloumanou EK, Karageorgopoulos DE, Kazantzi MS, Kapaskelis AM, Falagas ME. Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2009; 64:16–24.
crossref
21. Kitamura K, Iino Y, Kamide Y, Kudo F, Nakayama T, Suzuki K, et al. Clinical practice guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan: 2013 update. Auris Nasus Larynx. 2015; 42:99–106.
crossref
22. Kalu SU, Ataya RS, McCormick DP, Patel JA, Revai K, Chonmaitree T. Clinical spectrum of acute otitis media complicating upper respiratory tract viral infection. Pediatr Infect Dis J. 2011; 30:95–99.
crossref
23. Uitti JM, Tahtinen PA, Laine MK, Ruohola A. Close follow-up in children with acute otitis media initially managed without antimicrobials. JAMA Pediatr. 2016; 170:1107–1108.
crossref
24. Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J. 2000; 19:598–602.
crossref
25. Putto A, Ruuskanen O, Meurman O, Ekblad H, Korvenranta H, Mertsola J, et al. C reactive protein in the evaluation of febrile illness. Arch Dis Child. 1986; 61:24–29.
crossref
26. Huijskens EG, Biesmans RC, Buiting AG, Obihara CC, Rossen JW. Diagnostic value of respiratory virus detection in symptomatic children using real-time PCR. Virol J. 2012; 9:276.
crossref
27. van Woensel JB, van Aalderen WM, Kimpen JL. Viral lower respiratory tract infection in infants and young children. BMJ. 2003; 327:36–40.
crossref
28. Oosterheert JJ, van Loon AM, Schuurman R, Hoepelman AI, Hak E, Thijsen S, et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis. 2005; 41:1438–1444.
crossref
29. Rhedin S, Lindstrand A, Rotzen-Ostlund M, Tolfvenstam T, Ohrmalm L, Rinder MR, et al. Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics. 2014; 133:e538–e545.
crossref
TOOLS
Similar articles